TRAVERE THERAPEUTICS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
TRAVERE THERAPEUTICS, INC. (TVTX) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.62% for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2014-03-31 was 1.73%, a 101.16% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2013-03-31 was 0.86%, a 11.69% increase year-over-year.
- TRAVERE THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2012-03-31 was 0.77%.
- TRAVERE THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 1.39%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2014-06-30 | 1.62% 10-Q · filed 2014-08-14 | |||
| 2014-03-31 | 1.73% 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | 1.39% 10-K/A · filed 2015-07-09 | |||
| 2013-09-30 | 1.41% 10-Q/A · filed 2015-07-09 | |||
| 2013-06-30 | 0.86% 10-Q · filed 2013-09-16 | |||
| 2013-03-31 | 0.86% 10-Q/A · filed 2013-09-16 | |||
| 2012-06-30 | 1.41% 10-Q · filed 2013-09-16 | |||
| 2012-03-31 | 0.77% 10-Q/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |